On 7/11/16 Imugene announced Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study and since we have heard nothing about recruitment or patients being dosed.
I can’t help the feeling that if the potential market is as big as they say the announcement was either premature or the hospital programs were not ready because surely if there are that many patients suffering gastric cancer in Asia they would have started dosing almost immediately. I know from the experience of friends here in Australia that suitable patients can be recruited to tests with-in days of diagnosis and being deemed a suitable patient.
Lastest investor newsletter and preso mention nothing of a delay which I find worrying especially as testing is supposed to be occurring in 3 separate hospitals surely one would have found a suitable patient with-in 11 weeks.
no recruitments? no patients dosed?
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 877572 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |